MENU
+Compare
TRML
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$26.74
Change
+$1.64 (+6.53%)
Capitalization
687.01M

TRML Tourmaline Bio Forecast, Technical & Fundamental Analysis

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases... Show more

TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TRML with price predictions
Sep 05, 2025

TRML sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for TRML moved above the 200-day moving average on August 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 20, 2025. You may want to consider a long position or call options on TRML as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TRML just turned positive on September 03, 2025. Looking at past instances where TRML's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRML advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 172 cases where TRML Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRML declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRML broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.650) is normal, around the industry mean (20.126). P/E Ratio (0.000) is within average values for comparable stocks, (52.590). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.088). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (327.236).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRML’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRML’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APHHX26.840.03
+0.11%
Artisan Global Equity Institutional
TIEHX16.45N/A
N/A
Nuveen International Eq I
GLDIX39.30N/A
N/A
Gabelli Gold I
HNRGX28.51N/A
N/A
Hennessy Energy Transition Investor
CGRIX78.90-0.16
-0.20%
Calamos Growth I

TRML and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been loosely correlated with IMNM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TRML jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
+6.53%
IMNM - TRML
44%
Loosely correlated
+7.35%
STOK - TRML
43%
Loosely correlated
+5.35%
CRNX - TRML
43%
Loosely correlated
+3.97%
SYRE - TRML
41%
Loosely correlated
+0.06%
APGE - TRML
41%
Loosely correlated
+1.99%
More